Treacy Paul 4
4 · Jazz Pharmaceuticals plc · Filed Aug 13, 2018
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2018-08-10$176.61/sh−1,309$231,183→ 17,458 total
Footnotes (3)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $177.061. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Includes 126 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018.